We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+4.67%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$489B
AUM Growth
+$8.01B
Cap. Flow
-$30B
Cap. Flow %
-6.13%
Top 10 Hldgs %
29.25%
Holding
15,615
New
1,894
Increased
5,212
Reduced
6,339
Closed
1,910

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$1.71B
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$613M
3
AAPL icon
Apple
AAPL
+$478M
4
MA icon
Mastercard
MA
+$450M
5
QQQ icon
Invesco QQQ Trust
QQQ
+$424M

Sector Composition

Rank Sector Weight
1 Technology 3.12%
2 Financials 2.35%
3 Healthcare 2.22%
4 Consumer Discretionary 2.21%
5 Communication Services 1.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INTZ
13301
DELISTED
INTRUSION INC NEW
INTZ
$35K ﹤0.01%
+10,260
New +$35K
ANIX icon
13302
PUT
Anixa Biosciences
ANIX
$108M
$34K ﹤0.01%
11,500
-15,400
-57% -$62.3K
DLNG icon
13303
CALL
Dynagas LNG Partners
DLNG
$140M
$34K ﹤0.01%
11,600
-14,700
-56% -$45.2K
JAGX icon
13304
CALL
Jaguar Health
JAGX
$4.5M
0
LCTX icon
13305
PUT
Lineage Cell Therapeutics
LCTX
$271M
$34K ﹤0.01%
13,900
-900
-6% -$2.11K
NDRA icon
13306
ENDRA Life Sciences
NDRA
$5.68M
$34K ﹤0.01%
+1
New +$42.5K
VNRX icon
13307
VolitionRx Ltd
VNRX
$6.47M
$34K ﹤0.01%
547
-407
-43% -$27.8K
IVF
13308
PUT
INVO Fertility Inc
IVF
$1.74M
0
ONCT
13309
PUT
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$34K ﹤0.01%
750
-1,420
-65% -$95.5K
AXLA
13310
DELISTED
Axcella Health Inc. Common Stock
AXLA
$34K ﹤0.01%
654
-352
-35% -$24.7K
ARDS
13311
DELISTED
Aridis Pharmaceuticals Inc. Common Stock
ARDS
$34K ﹤0.01%
+14,734
New +$41.9K
FOXWW
13312
DELISTED
FoxWayne Enterprises Acquisition Corp. Warrant
FOXWW
$34K ﹤0.01%
83,818
-201
-0.2% -$97
SCPS
13313
DELISTED
Scopus BioPharma Inc. Common Stock
SCPS
$34K ﹤0.01%
+20,897
New +$63.3K
SWETW
13314
DELISTED
Athlon Acquisition Corp. Warrant
SWETW
$34K ﹤0.01%
56,208
NBEV
13315
PUT
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
$34K ﹤0.01%
33,000
-55,700
-63% -$73.5K
BLCT
13316
DELISTED
BlueCity Holdings Limited American Depositary Shares
BLCT
$34K ﹤0.01%
+22,342
New +$52.6K
EGY icon
13317
Vaalco Energy
EGY
$608M
$33K ﹤0.01%
10,422
-26,837
-72% -$89.1K
GECC icon
13318
Great Elm Capital Corp
GECC
$79M
$33K ﹤0.01%
+1,768
New +$36K
HOOK
13319
CALL
DELISTED
HOOKIPA Pharma
HOOK
$33K ﹤0.01%
1,430
-980
-41% -$39.4K
REFR icon
13320
Research Frontiers
REFR
$15.3M
$33K ﹤0.01%
19,327
-11,027
-36% -$23.6K
SLE icon
13321
CALL
Super League Enterprise
SLE
$3.65M
$33K ﹤0.01%
1
-9
-90% -$269K
SYPR icon
13322
CALL
Sypris Solutions
SYPR
$47.4M
$33K ﹤0.01%
+13,400
New +$43.2K
YARW
13323
Yarrow Bioscience, Inc. Common Stock
YARW
$113M
$33K ﹤0.01%
36
-29
-45% -$31.1K
XTIA icon
13324
XTI Aerospace
XTIA
$62.3M
0
ITCL
13325
DELISTED
Banco Itau Chile American Depositary Shares (each representing one third of one (1/3) Common Share)
ITCL
$33K ﹤0.01%
+11,453
New +$37.4K

Similar funds

Ken Griffin's Q4 2021 Portfolio in Review

As of Q4 2021, Ken Griffin held 15,615 positions worth $489B, up 1.7% from $481B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Ken Griffin withdrew a net $30B in Q4 2021, closing 1,910 positions and reducing 6,339 holdings. Its most notable exit was CIMAREX ENERGY CO, an estimated $279M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3.1% of assets, up from 3.1% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Ken Griffin opened a new position in iShares iBoxx $ High Yield Corporate Bond ETF worth $248M.

  • Ken Griffin's largest Q4 2021 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 2,847,920 shares worth $248M.
  • Ken Griffin added most to Amazon in Q4 2021, an estimated $802M increase.
  • Ken Griffin's biggest Q4 2021 reduction was Tesla, cutting an estimated $1.71B.
  • Ken Griffin fully exited CIMAREX ENERGY CO in Q4 2021, selling an estimated $279M.
  • Ken Griffin's ten largest holdings make up 29% of its $489B portfolio in Q4 2021.
  • Ken Griffin opened 1,894 new positions and closed 1,910 in Q4 2021.
  • Ken Griffin's portfolio value rose 1.7% quarter-over-quarter to $489B.

Based on Citadel Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.